Antimicrobial activity of quinoline-based hydroxyimidazolium hybrids
Cargando...
Fecha
Título de la revista
ISSN de la revista
Título del volumen
Editor
MDPI
Resumen
Descripción
Eight quinoline-based hydroxyimidazolium hybrids 7a–h were prepared and evaluated
in vitro against a panel of clinically important fungal and bacterial pathogens, including mycobacteria.
Hybrid compounds 7c–d showed remarkable antifungal activity against Cryptococcus neoformans
with a minimum inhibitory concentration (MIC) value of 15.6 µg/mL. Against other opportunistic
fungi such as Candida spp. and Aspergillus spp., these hybrids showed MIC values of 62.5 µg/mL.
Regarding their antibacterial activity, all the synthetic hybrids demonstrated little inhibition of
Gram-negative bacteria (MIC ≥50 µg/mL), however, hybrid 7b displayed >50% inhibition against
Klebsiella pneumoniae at 20 µg/mL and full inhibition at 50 µg/mL. Moreover, this hybrid was shown to
be a potent anti-staphylococcal molecule, with a MIC value of 2 µg/mL (5 µM). In addition, hybrid
7h also demonstrated inhibition of Staphylococcus aureus at 20 µg/mL (47 µM). Hybrids 7a and 7b
were the most potent against Mycobacterium tuberculosis H37Rv with MIC values of 20 and 10 µg/mL
(46 and 24 µM), respectively. The 7b hybrid demonstrated high selectivity in killing S. aureus and
M. tuberculosis H37Rv in comparison with mammalian cells (SI >20), and thus it can be considered a
hit molecule for mechanism of action studies and the exploration of related chemical space.
Para citar este articulo: Insuasty, D.; Vidal, O.; Bernal, A.; Marquez, E.; Guzman, J.; Insuasty, B.; Quiroga, J.; Svetaz, L.; Zacchino, S.; Puerto, G.; Abonia, R. Antimicrobial Activity of Quinoline-Based Hydroxyimidazolium Hybrids. Antibiotics 2019, 8, 239.
Para citar este articulo: Insuasty, D.; Vidal, O.; Bernal, A.; Marquez, E.; Guzman, J.; Insuasty, B.; Quiroga, J.; Svetaz, L.; Zacchino, S.; Puerto, G.; Abonia, R. Antimicrobial Activity of Quinoline-Based Hydroxyimidazolium Hybrids. Antibiotics 2019, 8, 239.
Citación
Aprobación
Revisión
Complementado por
Referenciado por
Licencia Creative Commons
Excepto donde se indique lo contrario, la licencia de este ítem se describe como Attribution 4.0 International (CC BY 4.0)

